Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05385354
Other study ID # MDP-1
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 3, 2022
Est. completion date May 3, 2024

Study information

Verified date December 2023
Source Technical University of Munich
Contact Veit T Phillip, MD
Phone +498941409350
Email veit.phillip@tum.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The maximal diameter of the pancreatic duct will be measured by endoscopic ultrasound at four different parts: - Pancreatic head - Pancreatic neck - Pancreatic body - Pancreatic tail


Description:

All patients without pancreatic or biliary disorders undergoing upper-GI endoscopic ultrasound (EUS) are eligible for the study. The maximal diameter of the pancreatic duct will be measured by endoscopic ultrasound in millimeters at four different parts: - Pancreatic head - Pancreatic neck - Pancreatic body - Pancreatic tail


Recruitment information / eligibility

Status Recruiting
Enrollment 102
Est. completion date May 3, 2024
Est. primary completion date May 3, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Patients undergoing EUS for investigation of non-pancratic disease (e.g. subeptithelial tumor of the upper GI-tract - Indication for EUS is undependent from the study - Written informed consent - Age =18 years Exclusion Criteria: - Pancreatic diseases (chronic or acute pancreatitis, pancreatic tumor, pancreatic cyst, etc.) - Disorders of papilla duodeni major/minor (adenoma/carcinoma of papilla duodeni major or minor) - Biliary disorders (bile duct stones, cholangio carcinoma, cholangitis) - Elevated Bilirubin and/or Lipase

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Clinic and Policlinik of Internal Medicine II Munich Bavaria

Sponsors (1)

Lead Sponsor Collaborator
Technical University of Munich

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal diameter of main pancreatic duct in millimeters Measurements of main pancreatic duct at different sections of the pancreas The measurement is performed once during endosonography.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04232670 - Pancreatic Endotherapy for Refractory Chronic Pancreatitis N/A